Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Horizon Pharma
Biotech
Horizon snaps up Curzion and its ex-Sanofi rare disease drug
Horizon Therapeutics has added to its growing acquisitive pipeline with the buyout of Curzion Pharmaceuticals for just $45 million.
Ben Adams
Apr 3, 2020 8:25am
Horizon eye drug wins FDA panel backing in unanimous vote
Dec 13, 2019 4:54pm
Horizon sets up Bay Area R&D, manufacturing site
Nov 22, 2019 10:15am
New phase 3 data paint fuller picture for Horizon's teprotumumab
Apr 26, 2019 2:05pm
Horizon Pharma's inflammatory eye drug aces phase 3
Feb 28, 2019 11:02am
Selecta unveils more data on its gout drug, plans phase 3 study
Jun 15, 2018 7:00am
